Publications by authors named "Feifeng Xi"

Claim this Profile
P
Phase I open-label study of the respiratory syncytial virus monoclonal antibody clesrovimab: Safety and tolerability in healthy Chinese participants.
Yulei He, Fengli Zhao, Xiao Yang, Shasha Xing, Feifeng Xi

Hum Vaccin Immunotherยท December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis